<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044862">
  <TermName>AG3340</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It is a matrix metalloproteinase inhibitor and belongs to the family of drugs called angiogenesis inhibitors. Also called prinomastat.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>AG3340</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un inhibidor de la metaloproteinasa de matriz y un tipo de inhibidor de la angiogénesis. También se llama prinomastat.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2005-02-15</DateLastModified>
</GlossaryTerm>
